Clinical Trial: A Prospective, Double Arm, Randomized Clinical Trial, to Assess Safety and Effectiveness of Spatial StimelMD (SSMD), in Subjects With Upper Limb Neuromotor Impairments.

U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07396922) titled 'A Prospective, Double Arm, Randomized Clinical Trial, to Assess Safety and Effectiveness of Spatial StimelMD (SSMD), in Subjects With Upper Limb Neuromotor Impairments.' on Feb. 02.

Brief Summary: This study will evaluate the safety and performance of the Spatial StimeMD (SSMD) medical device in people with multiple sclerosis (MS). The SSMD device is intended to support patients through a non-invasive stimulation program. The study will assess changes in MS-related symptoms and physical function using clinical assessments and patient-reported outcomes.

Study Start Date: Dec. 30, 2026

Study Type: INTERVENTIONAL

Condition: Stroke...